Authors:
Sperr, WR
Wimazal, F
Kundi, M
Fonatsch, C
Thalhammer-Scherrer, R
Schernthaner, GH
Schwarzinger, I
Haas, OA
Geissler, K
Lechner, K
Valent, P
Citation: Wr. Sperr et al., Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems, ANN HEMATOL, 80(5), 2001, pp. 272-277
Authors:
Geusau, A
Abraham, K
Geissler, K
Sator, MO
Stingl, G
Tschachler, E
Citation: A. Geusau et al., Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Clinical and laboratory effects, ENVIR H PER, 109(8), 2001, pp. 865-869
Authors:
Wagner, T
Fritsch, G
Thalhammer, R
Hocker, P
Lanzer, G
Lechner, K
Geissler, K
Citation: T. Wagner et al., IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+cells, TRANSFUSION, 41(5), 2001, pp. 659-666
Authors:
Ohler, L
Berer, A
Aletaha, D
Kabrna, E
Heinze, G
Streubel, B
Fonatsch, C
Haas, OA
Lechner, K
Geissler, K
Citation: L. Ohler et al., Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growth, BR J HAEM, 113(1), 2001, pp. 120-125
Authors:
Sperr, WR
Jordan, JH
Baghestanian, M
Kiener, HP
Samorapoompichit, P
Semper, H
Hauswirth, A
Schernthaner, GH
Chott, A
Natter, S
Kraft, D
Valenta, R
Schwartz, LB
Geissler, K
Lechner, K
Valent, P
Citation: Wr. Sperr et al., Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia, BLOOD, 98(7), 2001, pp. 2200-2209
Authors:
Geissler, K
Manafi, M
Amoros, I
Alonso, JL
Citation: K. Geissler et al., Quantitative determination of total coliforms and Escherichia coli in marine waters with chromogenic and fluorogenic media (vol 88, pg 280, 2000), J APPL MICR, 89(6), 2000, pp. 1066-1066
Authors:
Geissler, K
Manafi, M
Amoros, I
Alonso, JL
Citation: K. Geissler et al., Quantitative determination of total coliforms and Escherichia coli in marine waters with chromogenic and fluorogenic media, J APPL MICR, 88(2), 2000, pp. 280-285
Authors:
Locker, GJ
Stoiser, B
Losert, H
Wenzel, C
Ohler, L
Kabrna, E
Geissler, K
Citation: Gj. Locker et al., Decrease of circulating hematopoietic progenitor cells during interleukin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion, LEUK LYMPH, 39(3-4), 2000, pp. 355-364
Authors:
Oehler, L
Berer, A
Keil, F
Weinlander, G
Konig, M
Haas, OA
Lechner, K
Geissler, K
Citation: L. Oehler et al., Generation of dendritic cells from human chronic myelomonocytic leukemia cells in fetal calf serum-free medium, LEUK LYMPH, 38(5-6), 2000, pp. 577
Authors:
Oehler, L
Berer, A
Kollars, M
Keil, F
Konig, M
Waclavicek, M
Haas, O
Knapp, W
Lechner, K
Geissler, K
Citation: L. Oehler et al., Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia, ANN HEMATOL, 79(7), 2000, pp. 355-362
Citation: K. Geissler et T. Wagner, Cytokine combinations for the in-vivo and ex-vivo expansion of hematopoietic progenitor cells, ACT MED AUS, 27, 2000, pp. 21-24
Authors:
Berer, A
Stockl, J
Majdic, O
Wagner, T
Kollars, M
Lechner, K
Geissler, K
Oehler, L
Citation: A. Berer et al., 1,25-dihydroxyvitamin D-3 inhibits dendritic cell differentiation and maturation in vitro, EXP HEMATOL, 28(5), 2000, pp. 575-583
Authors:
Thalhammer-Scherrer, R
Veitl, M
Exner, M
Schneider, B
Geissler, K
Simonitsch, I
Schwarzinger, I
Citation: R. Thalhammer-scherrer et al., Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice, CYTOMETRY, 42(1), 2000, pp. 5-10
Authors:
Fureder, W
Streubel, B
Jordan, JH
Walchshofer, S
Wimazal, F
Jager, U
Geissler, K
Schwartz, LB
Chott, A
Lechner, K
Valent, P
Fonatsch, C
Citation: W. Fureder et al., Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvementin an unusual myelogenous disorder with bath myeloproliferative and dysplastic features, CANC GENET, 121(2), 2000, pp. 133-138
Authors:
Kuhr, T
Eisterer, W
Apfelbeck, U
Linkesch, W
Bechter, O
Zabernigg, A
Geissler, K
Barbieri, G
Duba, C
Gastl, G
Thaler, J
Citation: T. Kuhr et al., Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study, LEUK RES, 24(7), 2000, pp. 583-587